MANNKIND CORP
MNKD·56400P706·US·Common Stock·Healthcare - Biotechnology-13D/G
MNKD (MANNKIND CORP) is held by 139 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($70.1M), STATE STREET CORP ($45.8M), VANGUARD CAPITAL MANAGEMENT LLC ($31.6M). Net institutional sentiment: Mixed.
139
Holders
Avg rating(28 Elite)
$384.6M
Total Value
53% (157)
Fund Consensus
78 buying - 69 selling
Who's Trading
InsiderPBPrentiss Christopher BTax 12K shApr 22, 2026
InsiderCMCastagna MichaelBuy $259KMar 10, 2026
InsiderTATross Stuart ASell $298KJan 8, 2026
InsiderCMCastagna MichaelSell $395KDec 17, 2025
InsiderCMCastagna MichaelSell $128KDec 16, 2025
InsiderCMCastagna MichaelSell $125KDec 12, 2025
InsiderSRSingh Sanjay RSell $94KNov 14, 2025
InsiderTATross Stuart ASell $251KSep 16, 2025
13F: Insider & Congress:
Showing 1-20 of 157
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer